AmpliTech (US:AMPG)2025-11-14 14:32Financial Data and Key Metrics Changes - Quarterly revenue reached $6.09 million, a 115% increase compared to $2.83 million in Q3 2024 [4] - Gross profit more than doubled to $2.96 million, representing a 48.6% gross margin, up from 47.5% in the prior year [4] - EBITDA positive of nearly $200,000, indicating substantial improvement in operating performance [4] - Net loss narrowed significantly to $188,000 compared to a net loss of $1.19 million in Q3 2024 [4] - Year-to-date revenue surged 171% to $20.7 million compared to $7.7 million in the same period last year [5] - Net loss reduced by nearly 50%, improving from $7.4 million in 2024 to $3.8 million in 2025 [5] Business Line Data and Key Metrics Changes - Growth driven by the successful integration of AmpliTech's 5G ORAN technology and strong momentum in low-noise amplifiers and 5G infrastructure systems [5] - Continued investment in R&D increased by 60%, supporting new product development in MIMO 64P64R ORAN radios and private 5G network systems [5] Market Data and Key Metrics Changes - The company anticipates double-digit gross margins in Q4 2025 and 2026 as production costs normalize [7] - Projected revenue for fiscal year 2026 is at least $50 million, effectively doubling the projected record fiscal year 2025 revenue of at least $25 million [7] Company Strategy and Development Direction - The integration of ORAN IP portfolio positions AmpliTech as a U.S.-based vertically integrated supplier for next-generation open RAN 5G radios [6] - The company aims for a 25%-30% annual revenue growth through 2030, driven by ORAN 5G LOIs with two different customers [10] - The rights offering is designed to strengthen the balance sheet without incurring expensive debt, supporting growth while respecting long-term shareholders [12] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving profitability in fiscal year 2026, assuming the continuation of current order pace and margin recovery [7] - The company is positioned to deliver successive quarters of growth and enhanced shareholder value, with a healthy balance sheet and zero long-term debt [16] Other Important Information - The rights offering is priced at $4 per unit, providing growth capital for scaling ORAN product lines and expanding domestic production [6] - The company plans to use proceeds from the rights offering to scale production, fund inventory, and complete necessary certifications [14][15] Q&A Session Summary Question: Will the rights be traded when distributed? - Yes, the rights are expected to be traded when distributed [20][21] Question: Can you provide more details on gross margins for new products? - Specific gross margin information cannot be disclosed due to competitive nature, but the company expects at least double-digit gross margins on all products [23][24] Question: Historically, gross margins have been around 30-40%. Will this continue? - The company has recovered to over 40% gross margins in Q3 and will continue to allocate capital to improve margins [24][25]